Ad-hoc: Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond
Marinomed Biotech AG announces partnership for Budesolv in Switzerland
Marinomed Biotech AG announces results for the first quarter of 2025
Marinomed Biotech AG: Launch of new moisturizing Carragelose eye drops in Austria
Public Relations